Monographie - Neostigmine methylsulfate

Última actualização :
08/05/2024

Neostigmine methylsulfate

Estrutura química

Nomes comerciais nos diversos países

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Adwigmine	Egipto
Amostigmine	Egipto
Beemine	Índia
Bloxiverz
Epistigmine	Egipto
Fadastigmina	Argentina, Itália, Portugal
Ipostigmine	Irã
Miostin	Romènia
Neostig	Alemanha
Neostigmin	Alemanha, Suècia
Neostigmina	Argentina, Chilli, Colômbia, Equator, Espanha, Peru, Portugal, Venezuela
Neostigmine	Arábia Saudita, Australia, Canadá, Egipto, Gran-bretanha, Grècia, Irlanda, Malásia, Nova Zelândia, Países Baixos, Turquia
Neostigmine methylsulfate	Canadá
Neostigten	Peru
Normastigmin	Austria
Planstigmin	Turquia
Polstigminum	Polonia
Prostigmin	Austria, Bélgica, Grècia, Malásia, Países Baixos, Suicia
Prostigmina	Itália
Prostigmine	Bélgica, Chilli, Colômbia, Egipto, Emirados Árabes Unidos, Espanha, França, Luxemburgo, Marrocos, México, Venezuela
Setisin	Malásia
Stigmosan	Hungria
Tigmin	Peru
Visulmin	México

Bibliografía : Neostigmine methylsulfate

	Tipo	Publicação
815	Jornal	Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL. Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
1200	Jornal	Chaudry IA, Bruey KP, Hurlburt LE, Oden EM. Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives. Am J Hosp Pharm 1981 ; 38: 1737-1742.
1228	Jornal	Allen LV, Stiles ML. Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2. Am J Hosp Pharm 1981 ; 38: 380-381.
1682	Jornal	Storms M, Stewart JT, Warren FW. Stability of neostigmine methylsulfate injection at ambient temperature and 4°C in polypropylene syringes. Int J Pharm Compound 2002 ; 6: 475-477.
2286	Jornal	Ben M, Trusley C, Kupiec TC, Trissel LA. Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration. Int J Pharm Compound 2008 ; 12, 4: 368-371.
2291	Jornal	Yeh MK. Degradation kinetics of neostigmine in solution. Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.
3372	Jornal	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3578	Laboratório	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3599	Laboratório	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3644	Laboratório	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010

Mentions Légales